» Articles » PMID: 29959257

Subjective Cognitive Decline and Risk of MCI: The Mayo Clinic Study of Aging

Overview
Journal Neurology
Specialty Neurology
Date 2018 Jul 1
PMID 29959257
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We investigated different dimensions of subjective cognitive decline (SCD) to determine which was the best prognostic risk factor for incident mild cognitive impairment (MCI) among cognitively unimpaired participants.

Methods: We included 1,167 cognitively unimpaired participants, aged 70 to 95 years, from the Mayo Clinic Study of Aging based on 2 concurrent SCD scales (part of the Blessed memory test and the 39-item Everyday Cognition [ECog] scale, which included a validated 12-item derivative) and a single question assessing worry about cognitive decline. We evaluated multiple ways to dichotomize scores. In continuous models, we compared average scores on 4 ECog domains and multidomain (39- and 12-item) ECog scores. Cox proportional hazards models were used to assess the association between each measure and risk of MCI in models adjusted for objective memory performance, depression, anxiety, sex, ε4 carriership, and medical comorbidities.

Results: It was possible to select a substantial group of participants (14%) at increased risk of incident MCI based on combined baseline endorsement of any consistent SCD on the ECog (any item scored ≥3; 12-item ECog hazard ratio [HR] 2.17 [95% confidence interval 1.51-3.13]) and worry (HR 1.79 [1.24-2.58]) in an adjusted model combining these dimensions. In continuous models, all ECog domains and the multidomain scores were associated with risk of MCI with a small advantage for multidomain SCD (12-item ECog HR 2.13 [1.36-3.35] per point increase in average score). Information provided by the informant performed comparable to self-perceived SCD.

Conclusion: Prognostic value of SCD for incident MCI improves when both consistency of SCD and associated worry are evaluated.

Citing Articles

The impact of depression and anxiety on the correlation between somatic symptom disorder and subjective cognitive decline in the Chinese elderly population: an exploration by simple, serial, and moderated mediation models.

Lin Y, Lin P, Zeng G, Wu S, Chen R, Xiao Y Front Psychol. 2025; 16:1545325.

PMID: 40028648 PMC: 11868093. DOI: 10.3389/fpsyg.2025.1545325.


Association between BrainAGE and Alzheimer's disease biomarkers.

Abughofah Y, Deardorff R, Vosmeier A, Hottle S, Dage J, Dempsey D Alzheimers Dement (Amst). 2025; 17(1):e70094.

PMID: 40018325 PMC: 11865712. DOI: 10.1002/dad2.70094.


A mobile-based multidomain lifestyle intervention using Cognitive Evergreenland for older adults with subjective cognitive decline: a feasibility study.

Lin R, Yan Y, Chen Z, Huang C, Zhao J, Chen M BMC Geriatr. 2025; 25(1):41.

PMID: 39833671 PMC: 11744829. DOI: 10.1186/s12877-025-05684-4.


Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.

Rabinovici G, Knopman D, Arbizu J, Benzinger T, Donohoe K, Hansson O Alzheimers Dement. 2025; 21(1):e14338.

PMID: 39776249 PMC: 11772739. DOI: 10.1002/alz.14338.


Subjective cognitive decline predicts longitudinal neuropsychological test performance in an unsupervised online setting in the Brain Health Registry.

Kang J, Manjavong M, Jin C, Diaz A, Ashford M, Eichenbaum J Alzheimers Res Ther. 2025; 17(1):10.

PMID: 39773247 PMC: 11706033. DOI: 10.1186/s13195-024-01641-2.


References
1.
Blessed G, Tomlinson B, Roth M . The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968; 114(512):797-811. DOI: 10.1192/bjp.114.512.797. View

2.
Farias S, Mungas D, Harvey D, Simmons A, Reed B, DeCarli C . The measurement of everyday cognition: development and validation of a short form of the Everyday Cognition scales. Alzheimers Dement. 2011; 7(6):593-601. PMC: 3211103. DOI: 10.1016/j.jalz.2011.02.007. View

3.
Slavin M, Sachdev P, Kochan N, Woolf C, Crawford J, Giskes K . Predicting Cognitive, Functional, and Diagnostic Change over 4 Years Using Baseline Subjective Cognitive Complaints in the Sydney Memory and Ageing Study. Am J Geriatr Psychiatry. 2014; 23(9):906-14. DOI: 10.1016/j.jagp.2014.09.001. View

4.
Pfeffer R, Kurosaki T, Harrah Jr C, Chance J, Filos S . Measurement of functional activities in older adults in the community. J Gerontol. 1982; 37(3):323-9. DOI: 10.1093/geronj/37.3.323. View

5.
Mielke M, Wiste H, Weigand S, Knopman D, Lowe V, Roberts R . Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology. 2012; 79(15):1570-7. PMC: 3475629. DOI: 10.1212/WNL.0b013e31826e2696. View